
AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte
The AI in Business Podcast
00:00
Transforming Regulatory Functions with Generative AI in Drug Development
The chapter explores the challenges and considerations of using generative AI in drug development, emphasizing the need for human oversight for accuracy and compliance. It discusses the potential of generative AI to revolutionize regulatory functions in pharmaceutical R&D. The importance of combining domain expertise with AI knowledge and preparing employees for AI adoption is highlighted.
Transcript
Play full episode